Companies House does not verify the accuracy of the information filed

IMMUNOCORE LIMITED

Company number 06456207

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
11 May 2021	RP04SH01	Second filing of a statement of capital following an allotment of shares on 19 October 2020 GBP 542.9898	View PDF Second filing of a statement of capital following an allotment of shares on 19 October 2020 GBP 542.9898 - link opens in a new window - 5 pages (5 pages)
06 May 2021	RP04SH01	Second filing of a statement of capital following an allotment of shares on 3 September 2020 GBP 542.9651	View PDF Second filing of a statement of capital following an allotment of shares on 3 September 2020 GBP 542.9651 - link opens in a new window - 5 pages (5 pages)
28 Apr 2021	RP04SH01	Second filing of a statement of capital following an allotment of shares on 24 June 2020 GBP 542.9421	View PDF Second filing of a statement of capital following an allotment of shares on 24 June 2020 GBP 542.9421 - link opens in a new window - 5 pages (5 pages)
28 Apr 2021	AA	Group of companies' accounts made up to 31 December 2020	View PDF Group of companies' accounts made up to 31 December 2020 - link opens in a new window - 92 pages (92 pages)
23 Apr 2021	RP04SH01	Second filing of a statement of capital following an allotment of shares on 19 March 2020 GBP 542.8480	View PDF Second filing of a statement of capital following an allotment of shares on 19 March 2020 GBP 542.8480 - link opens in a new window - 5 pages (5 pages)
04 Feb 2021	PSC05	Change of details for Immunocore Holdings Limited as a person with significant control on 1 February 2021	View PDF Change of details for Immunocore Holdings Limited as a person with significant control on 1 February 2021 - link opens in a new window - 2 pages (2 pages)
04 Feb 2021	SH06	Cancellation of shares. Statement of capital on 3 March 2020 GBP 542.9421	View PDF Cancellation of shares. Statement of capital on 3 March 2020 GBP 542.9421 - link opens in a new window - 8 pages (8 pages)
04 Feb 2021	SH03	Purchase of own shares.	View PDF Purchase of own shares. - link opens in a new window - 3 pages (3 pages)
02 Feb 2021	CS01	Confirmation statement made on 18 December 2020 with updates	View PDF Confirmation statement made on 18 December 2020 with updates - link opens in a new window - 14 pages (14 pages)
01 Feb 2021	MA	Memorandum and Articles of Association	View PDF Memorandum and Articles of Association - link opens in a new window - 27 pages (27 pages)
01 Feb 2021	RESOLUTIONS	Resolutions RES12 ‐ Resolution of varying share rights or name	View PDF Resolutions RES12 ‐ Resolution of varying share rights or name - link opens in a new window - 3 pages (3 pages)
01 Feb 2021	SH10	Particulars of variation of rights attached to shares	View PDF Particulars of variation of rights attached to shares - link opens in a new window - 2 pages (2 pages)
01 Feb 2021	SH08	Change of share class name or designation	View PDF Change of share class name or designation - link opens in a new window - 2 pages (2 pages)
26 Jan 2021	PSC02	Notification of Immunocore Holdings Limited as a person with significant control on 22 January 2021	View PDF Notification of Immunocore Holdings Limited as a person with significant control on 22 January 2021 - link opens in a new window - 2 pages (2 pages)
26 Jan 2021	PSC09	Withdrawal of a person with significant control statement on 26 January 2021	View PDF Withdrawal of a person with significant control statement on 26 January 2021 - link opens in a new window - 2 pages (2 pages)
26 Jan 2021	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 1 page (1 page)
26 Jan 2021	SH19	Statement of capital on 26 January 2021 GBP 0.01	View PDF Statement of capital on 26 January 2021 GBP 0.01 - link opens in a new window - 3 pages (3 pages)
26 Jan 2021	CAP-SS	Solvency Statement dated 25/01/21	View PDF Solvency Statement dated 25/01/21 - link opens in a new window - 1 page (1 page)
26 Jan 2021	RESOLUTIONS	Resolutions RES06 ‐ Resolution of reduction in issued share capital RES13 ‐ Cancel share prem a/c 25/01/2021	View PDF Resolutions RES06 ‐ Resolution of reduction in issued share capital RES13 ‐ Cancel share prem a/c 25/01/2021 - link opens in a new window - 1 page (1 page)
26 Jan 2021	TM01	Termination of appointment of Kristine Peterson as a director on 24 January 2021	View PDF Termination of appointment of Kristine Peterson as a director on 24 January 2021 - link opens in a new window - 1 page (1 page)
26 Jan 2021	TM01	Termination of appointment of Peter John Ratcliffe as a director on 24 January 2021	View PDF Termination of appointment of Peter John Ratcliffe as a director on 24 January 2021 - link opens in a new window - 1 page (1 page)
26 Jan 2021	TM01	Termination of appointment of Robert Perez as a director on 24 January 2021	View PDF Termination of appointment of Robert Perez as a director on 24 January 2021 - link opens in a new window - 1 page (1 page)
26 Jan 2021	TM01	Termination of appointment of Bahija Jallal as a director on 24 January 2021	View PDF Termination of appointment of Bahija Jallal as a director on 24 January 2021 - link opens in a new window - 1 page (1 page)
26 Jan 2021	TM01	Termination of appointment of John Irving Bell as a director on 24 January 2021	View PDF Termination of appointment of John Irving Bell as a director on 24 January 2021 - link opens in a new window - 1 page (1 page)
26 Jan 2021	TM01	Termination of appointment of Travis Alan Coy as a director on 24 January 2021	View PDF Termination of appointment of Travis Alan Coy as a director on 24 January 2021 - link opens in a new window - 1 page (1 page)

Cookies on Companies House services

IMMUNOCORE LIMITED

Filter by category